BCM
ADVM

Bridgeway Capital Management’s Adverum Biotechnologies ADVM Stock Holding History

Bridgeway Capital Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,000
Closed -$79.5K – 1364
2023
Q2 		$79.5K Buy
+5,000
New +$52.6K ﹤0.01% 1287
2022
Q4 		– Sell
-29,900
Closed -$284K – 1367
2022
Q3 		$284K Buy
29,900
+5,700
+24% +$74.9K 0.01% 1060
2022
Q2 		$290K Hold
24,200
– – 0.01% 1001
2022
Q1 		$317K Buy
+24,200
New +$354K 0.01% 1057
2019
Q2 		– Sell
-22,360
Closed -$1.17M – 1306
2019
Q1 		$1.17M Buy
22,360
+3,440
+18% +$139K 0.01% 701
2018
Q4 		$596K Hold
18,920
– – 0.01% 939
2018
Q3 		$1.15M Hold
18,920
– – 0.01% 831
2018
Q2 		$1M Hold
18,920
– – 0.01% 877
2018
Q1 		$1.1M Buy
18,920
+530
+3% +$33K 0.01% 815
2017
Q4 		$644K Hold
18,390
– – 0.01% 1010
2017
Q3 		$671K Hold
18,390
– – 0.01% 995
2017
Q2 		$460K Hold
18,390
– – 0.01% 1110
2017
Q1 		$497K Sell
18,390
-17,950
-49% -$511K 0.01% 1076
2016
Q4 		$1.05M Buy
36,340
+2,310
+7% +$75.5K 0.01% 803
2016
Q3 		$1.4M Buy
34,030
+20,126
+145% +$763K 0.02% 667
2016
Q2 		$439K Sell
13,904
-8,546
-38% -$386K 0.01% 1098
2016
Q1 		$1.16M Buy
22,450
+3,020
+16% +$169K 0.02% 703
2015
Q4 		$1.85M Buy
19,430
+13,620
+234% +$1.2M 0.03% 516
2015
Q3 		$479K Buy
+5,810
New +$742K 0.01% 1054

Other funds holding ADVM

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

Bridgeway Capital Management's ADVM Position: Q3 2023 in Review

Bridgeway Capital Management sold out of Adverum Biotechnologies (ADVM) in Q3 2023, closing a stake of 5,000 shares — an estimated $79.5K sold.

Bridgeway Capital Management first reported a position in ADVM in Q3 2015 and held it in 19 quarters. The position peaked at $1.85M in Q4 2015. 59 funds tracked by Wall St. Rank hold ADVM as of Q3 2023.

  • Bridgeway Capital Management reported no remaining Adverum Biotechnologies position as of Q3 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 5,000 Adverum Biotechnologies shares in Q3 2023, an estimated $79.5K.
  • Bridgeway Capital Management first reported a position in Adverum Biotechnologies in Q3 2015 and held it in 19 quarters.
  • Bridgeway Capital Management's Adverum Biotechnologies position peaked at $1.85M in Q4 2015.
  • 59 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.